| (210) | Number of the EPO application | 17796828 |
| (220) | Filing date of the EPO application | 2017.05.11 |
| (80) | EPO patent specification publication (B) | EPB nr. 17/2021, 2021.04.28 |
| (110) | EPO patent number | 3454854 |
| (21) | Number of the application | e 2019 0340 |
| (71) | Name(s) of applicant(s), code of the country | Global Blood Therapeutics, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | LI Zhe, US;
GUZ Nathan, US;
SHAO Yiyang, US;
COCUZ Julieana, US;
FRIESER Markus, US;
YIANNIKOUROS George Petros, US;
LIAO Liang, US; |
| (73) | Name(s) of owner(s), code of the country | Global Blood Therapeutics, Inc., US; |
| (54) | Title of the invention | PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/44 (2006.01.01); C07D 231/02 (2006.01.01); C07D 401/04 (2006.01.01); C07C 45/65 (2006.01.01); C07C 47/56 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.04.30 |
| (30) | Priority | 201662335583 P, 2016.05.12, US |
| (86) | International application | PCT/US2017/032104, 2017.05.11 |
| (87) | International publication | WO 2017/197083, 2017.11.16 |